Comprehensive Pathology Solutions
Driving research and drug development with expert histopathology and molecular pathology
- NovoVita supports every stage of drug development with accurate, high-quality histopathology and molecular pathology. Driving breakthrough science on your timeline.
- Our state-of-the-art laboratory is equipped with the latest in cutting-edge technology, ensuring data accuracy, consistency, quality control and cost-efficiency at every stage.
- We are proud to be a 100% minority and woman-owned CLIA-certified high-complexity laboratory.
- With locations in the Boston area and Hong Kong, we’re expanding our global footprint and leveraging our skills, experience, and cultural insight to support clients across Mainland China and Southeast Asia.
Histopathology Services Customized to your Needs
Our scientists bring decades of deep expertise and hands-on experience in the bio-pharma industry. We have the capability to handle your needs as they evolve and offer a wide range of advanced services with superior outcomes.
Our services include histopathology, molecular pathology, digital pathology, preclinical and clinical biomarker development and validation, as well as support for clinical trials.
Our approach integrates advanced technology with expert scientific guidance to provide support throughout every stage of your project.
Trusted Partner for High-Quality, Time-Critical Histopathology
It is always a pleasure working with the NovoVita team: They provide expert pathology and professional results and always have cordial customer service utilizing a highly reproducible (automated) platform. They have the fastest turnaround of all the histopathology CROs we have engaged with. Great professionals to engage with when timelines are aggressive."
Director of Biology at a Watertown Pharmaceutical Company
I’ve worked with the NovoVita team over the past two years on preclinical model characterization, antibody validation, and exploratory IHC method development. They consistently deliver high-quality data on time and help keep projects moving smoothly. It’s been a truly collaborative and productive experience.”
Associate Director at a Boston Biotech Company
We had an outstanding experience with NovoVita’s histopathology services. Their ability to deliver high-quality results within tight timelines truly exceeded our expectations. The team demonstrated exceptional flexibility in accommodating our evolving project needs and provided expert support throughout the process. We highly value the partnership we have built together.
VP at a Rapidly Growing Biotech Company in Cambridge (MA)
Where efficiency meets collaboration
We believe successful science starts with strong partnerships. That’s why we prioritize quality assurance, communication, flexibility, and transparency at every stage.
Start with a Free Consultation
Submit a new client intake form and start with a consultation
Service Agreement
Receive and review the Confidential Disclosure Agreement (CDA), Master Service Agreement (MSA) and the Scope of Work (SOW), outlining scope, quote and timeline
Sample Submission
Send your samples by mail, overnight courier or drop them off at our laboratory during regular business hours
Sample Processing, and Ongoing Communication
Stay informed with timely updates as your samples are processed
Final Report and Online Results
Access your final report and images 24/7 from anywhere in the world via our secure, cloud-based Client Portal
24/7 Digital Pathology Access via Secure Client Portal
Enjoy secure, digital access to your images, annotations, and analytical results any time of the day or night from anywhere in the world through your customized Client Portal (HALO Link). Designed for global biotech collaboration, our secure platform ensures your team stays connected with real-time data insights, wherever your research takes you.
Our Certifications:

CAP Certification No: 7690634

CLIA Certification No: 22D2185074

Massachusetts Clinical Laboratory No: 5485

ISO 9001 Certification
No: 112021.00

Supplier Diversity Office Certification No: 20210107